Aspirin Use After Diagnosis Improves Survival in Older Adults with Colon Cancer: A Retrospective Cohort Study

Objectives To assess survival in relation to aspirin use after diagnosis in older adults with colon cancer. Design Subgroup analysis of a previously published cohort and retrospective study. Setting Individuals registered in the Eindhoven Cancer Registry (ECR) between 1998 and 2007, linked to prescr...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Geriatrics Society (JAGS) Vol. 60; no. 12; pp. 2232 - 2236
Main Authors Reimers, Marlies S., Bastiaannet, Esther, van Herk-Sukel, Myrthe P. P., Lemmens, Valery E. P., van den Broek, Colette B. M., van de Velde, Cornelis J. H., de Craen, Anton J. M., Liefers, Gerrit Jan
Format Journal Article
LanguageEnglish
Published Hoboken, NJ Blackwell Publishing Ltd 01.12.2012
Wiley-Blackwell
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0002-8614
1532-5415
1532-5415
DOI10.1111/jgs.12033

Cover

More Information
Summary:Objectives To assess survival in relation to aspirin use after diagnosis in older adults with colon cancer. Design Subgroup analysis of a previously published cohort and retrospective study. Setting Individuals registered in the Eindhoven Cancer Registry (ECR) between 1998 and 2007, linked to prescriptions of low‐dose aspirin (80 mg) registered in a community pharmacy database. Participants Five hundred thirty‐six individuals aged 70 and older diagnosed with colon cancer with or without aspirin use after diagnosis. Measurements Survival was analyzed with user status as a time‐dependent covariate. Multivariate Poisson regression survival models were used to study the effect of aspirin on overall survival. Results One hundred seven participants (20.0%) started aspirin after being diagnosed with colon cancer; 429 (80.0%) were not prescribed aspirin. Three hundred thirty‐nine participants (63.2%) had died by the end of follow‐up. Aspirin use after diagnosis was associated with longer overall survival (rate ratio (RR) = 0.51, 95% confidence interval (CI) = 0.38–0.70, P < .001). Multivariate proportional hazards regression analysis revealed that aspirin use was associated with longer overall survival (adjusted RR = 0.59, 95% CI = 0.44–0.81, P = .001). Conclusion Aspirin use after the diagnosis of colon cancer in older adults was associated with longer survival. Low‐dose aspirin could be used as an effective adjuvant therapy in older adults with colon cancer.
Bibliography:ArticleID:JGS12033
ark:/67375/WNG-B79GQFFS-N
istex:16BB57E83326C570A25AAFEB7AA92EDA4E620151
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0002-8614
1532-5415
1532-5415
DOI:10.1111/jgs.12033